CY1106528T1 - Μεθοδος θεραπειας δερματωσεων με τη χρηση ενωσης αβερμεκτινης - Google Patents
Μεθοδος θεραπειας δερματωσεων με τη χρηση ενωσης αβερμεκτινηςInfo
- Publication number
- CY1106528T1 CY1106528T1 CY20071100535T CY071100535T CY1106528T1 CY 1106528 T1 CY1106528 T1 CY 1106528T1 CY 20071100535 T CY20071100535 T CY 20071100535T CY 071100535 T CY071100535 T CY 071100535T CY 1106528 T1 CY1106528 T1 CY 1106528T1
- Authority
- CY
- Cyprus
- Prior art keywords
- avermectin compound
- treatment method
- skin treatment
- acne
- dermatitis
- Prior art date
Links
- -1 AVERMECTIN COMPOUND Chemical class 0.000 title abstract 2
- 239000005660 Abamectin Substances 0.000 title abstract 2
- 201000004624 Dermatitis Diseases 0.000 abstract 2
- 206010000496 acne Diseases 0.000 abstract 2
- 208000002874 Acne Vulgaris Diseases 0.000 abstract 1
- 206010000518 Acne varioliformis Diseases 0.000 abstract 1
- 208000002782 Acneiform Eruptions Diseases 0.000 abstract 1
- 208000009675 Perioral Dermatitis Diseases 0.000 abstract 1
- 230000001436 acantholytic effect Effects 0.000 abstract 1
- 208000017520 skin disease Diseases 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
- 230000001052 transient effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Abstract
Ανακοινώνεται μέθοδος για τη θεραπεία δερματώσεων μεταξύ των οποίων της μεταβατικής ακανθολυτικής δερματίτιδας, της ακμής miliaris necrotica, της ακμής varioliformis, της περιστοματικής δερματίτιδας και των ακμοειδών εξανθημάτων. Η μέθοδος περιλαμβάνει τοπική εφαρμογή δερματολογικής σύνθεσης, που περιέχει ένωση αβερμεκτίνης στις περιοχές ασθενή που έχουν προσβληθεί.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/976,915 US6399651B1 (en) | 2000-06-29 | 2001-10-12 | Method of treating dermatoses using avermectin compound |
PCT/US2002/032001 WO2003032976A1 (en) | 2001-10-12 | 2002-10-03 | Method of treating dermatoses using avermectin compound |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1106528T1 true CY1106528T1 (el) | 2012-01-25 |
Family
ID=25524622
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20071100535T CY1106528T1 (el) | 2001-10-12 | 2007-04-19 | Μεθοδος θεραπειας δερματωσεων με τη χρηση ενωσης αβερμεκτινης |
Country Status (9)
Country | Link |
---|---|
US (2) | US6399651B1 (el) |
EP (1) | EP1450785B1 (el) |
AT (1) | ATE352298T1 (el) |
CY (1) | CY1106528T1 (el) |
DE (1) | DE60217900T2 (el) |
DK (1) | DK1450785T3 (el) |
ES (1) | ES2278046T3 (el) |
PT (2) | PT1450785E (el) |
WO (1) | WO2003032976A1 (el) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7897559B2 (en) * | 2000-06-29 | 2011-03-01 | Parks L Dean | Dermatological composition and kit containing avermectin compound for treating dermatological conditions |
US6399651B1 (en) * | 2000-06-29 | 2002-06-04 | L. Dean Parks | Method of treating dermatoses using avermectin compound |
FR2854074B1 (fr) * | 2003-04-24 | 2007-11-23 | Galderma Res & Dev | Utilisation de l'ivermectine pour le traitement de desordres dermatologiques |
RU2350333C3 (ru) * | 2003-04-24 | 2018-08-24 | Галдерма С.А. | Применение ивермектина для лечения дерматологических расстройств |
GB0316377D0 (en) * | 2003-07-12 | 2003-08-13 | Norbrook Lab Ltd | Parasiticidal composition |
US7714015B2 (en) * | 2003-08-07 | 2010-05-11 | Lil Brat Pharmaceuticals Of Marlette, Mi | Method and composition for treating sunburned skin |
DE102004009904A1 (de) * | 2004-02-26 | 2005-09-22 | Grünenthal GmbH | Kit aus einem gegebenenfalls wirkstoffhaltigen Pflaster und einem Hautirritationen verhindernden Mittel |
FR2867684B1 (fr) * | 2004-03-18 | 2006-05-05 | Galderma Sa | Gel creme contenant de l'ivermectine |
DE602005020912D1 (de) * | 2004-03-18 | 2010-06-10 | Galderma Sa | Ivermectin enthaltende creme |
FR2894823B1 (fr) * | 2005-12-20 | 2008-02-29 | Galderma Sa | Composition de type emulsion inverse comprenant de l'ivermectine, et ses utilisations en cosmetique et en dermatologie |
FR2900052B1 (fr) * | 2006-04-19 | 2011-02-18 | Galderma Sa | Composition comprenant au moins une phase aqueuse et au moins une phase grasse comprenant de l'ivermectine |
FR2906468B1 (fr) * | 2006-09-28 | 2012-09-21 | Galderma Sa | Utilisation de composes de la famille des avermectines pour le traitement de desordres dermatologiques |
US8791153B2 (en) | 2006-10-12 | 2014-07-29 | Sanofi-Topaz, Inc. | Topical avermectin formulations and methods for elimination and prophylaxis of susceptible and treatment-resistant strains of head lice |
US8901163B2 (en) | 2007-01-03 | 2014-12-02 | Galderma S.A. | Method of treating hyperesthesia, paresthesia, dolor, and pruritus caused by insect stings or noxious weeds or plants using avermectin compound |
US20080226701A1 (en) * | 2007-03-15 | 2008-09-18 | John Deignan | Medicated patches |
US8541022B2 (en) * | 2008-06-02 | 2013-09-24 | Galderma S.A. | Method of treating burns using avermectin compound |
FR2937972B1 (fr) | 2008-11-04 | 2013-03-29 | Galderma Res & Dev | Derives d'oxoazetidine, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique |
CA2811924C (en) | 2010-10-20 | 2015-06-16 | Galderma S.A. | Method of treating hemorrhoids using macrocyclic lactone compound |
CA2811926A1 (en) | 2010-10-20 | 2012-04-26 | Galderma S.A. | Method of treating otitis externa using macrocyclic lactone compound |
US8722636B2 (en) * | 2011-01-31 | 2014-05-13 | New Market Pharmaceuticals, LLC | Animal treatments |
CN102599178B (zh) * | 2012-02-13 | 2013-11-27 | 中国水稻研究所 | 异丙威和依维菌素复配农药 |
AU2012379005B2 (en) | 2012-05-02 | 2017-12-21 | Newmarket Pharmaceuticals Llc | Pharmaceutical compositions for direct systemic introduction |
US9782425B2 (en) | 2013-07-08 | 2017-10-10 | Galderma S.A. | Treatment of papulopustular rosacea with ivermectin |
US9233117B2 (en) | 2013-07-08 | 2016-01-12 | Galderma S. A. | Treatment of inflammatory lesions of rosacea with ivermectin |
EP3074021B1 (en) * | 2013-11-29 | 2021-05-12 | Galderma SA | Compound of the avermectin family or of the milbemycin family for the treatment and/or prevention of atopic dermatitis |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE434277B (sv) * | 1976-04-19 | 1984-07-16 | Merck & Co Inc | Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis |
US5439924A (en) * | 1991-12-23 | 1995-08-08 | Virbac, Inc. | Systemic control of parasites |
US5786344A (en) * | 1994-07-05 | 1998-07-28 | Arch Development Corporation | Camptothecin drug combinations and methods with reduced side effects |
US5654312A (en) * | 1995-06-07 | 1997-08-05 | Andrulis Pharmaceuticals | Treatment of inflammatory and/or autoimmune dermatoses with thalidomide alone or in combination with other agents |
US5773422A (en) * | 1996-01-29 | 1998-06-30 | Komer; Gene | Avermectin formulation |
US6057372A (en) * | 1996-06-11 | 2000-05-02 | Soda Aromatic Co., Ltd. | Antibacterial agents and cosmetics and clothing containing the same |
US5952372A (en) * | 1998-09-17 | 1999-09-14 | Mcdaniel; William Robert | Method for treating rosacea using oral or topical ivermectin |
US6262031B1 (en) * | 1999-03-12 | 2001-07-17 | Merck & Co., Inc. | Method for treating pediculosis capitisinfestation |
US6133310A (en) * | 1999-08-26 | 2000-10-17 | Parks; L. Dean | Method of treatment of rosacea |
US6399651B1 (en) * | 2000-06-29 | 2002-06-04 | L. Dean Parks | Method of treating dermatoses using avermectin compound |
US6319945B1 (en) * | 2000-06-29 | 2001-11-20 | L. Dean Parks | Method of treatment of seborrheic dermatitis |
US6399652B1 (en) * | 2000-06-29 | 2002-06-04 | L. Dean Parks | Method of treating acne vulgaris using avermectin compound |
-
2001
- 2001-10-12 US US09/976,915 patent/US6399651B1/en not_active Expired - Lifetime
-
2002
- 2002-06-03 US US10/159,938 patent/US20020156029A1/en not_active Abandoned
- 2002-10-03 PT PT02766531T patent/PT1450785E/pt unknown
- 2002-10-03 PT PT02768995T patent/PT1439832E/pt unknown
- 2002-10-03 WO PCT/US2002/032001 patent/WO2003032976A1/en active IP Right Grant
- 2002-10-03 DE DE60217900T patent/DE60217900T2/de not_active Expired - Lifetime
- 2002-10-03 ES ES02766531T patent/ES2278046T3/es not_active Expired - Lifetime
- 2002-10-03 EP EP02766531A patent/EP1450785B1/en not_active Expired - Lifetime
- 2002-10-03 DK DK02766531T patent/DK1450785T3/da active
- 2002-10-03 AT AT02766531T patent/ATE352298T1/de active
-
2007
- 2007-04-19 CY CY20071100535T patent/CY1106528T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
ATE352298T1 (de) | 2007-02-15 |
US20020156029A1 (en) | 2002-10-24 |
PT1439832E (pt) | 2007-06-05 |
EP1450785A1 (en) | 2004-09-01 |
US6399651B1 (en) | 2002-06-04 |
ES2278046T3 (es) | 2007-08-01 |
DE60217900T2 (de) | 2007-11-08 |
EP1450785B1 (en) | 2007-01-24 |
EP1450785A4 (en) | 2005-01-05 |
US20020035076A1 (en) | 2002-03-21 |
WO2003032976A1 (en) | 2003-04-24 |
DK1450785T3 (da) | 2007-05-14 |
DE60217900D1 (de) | 2007-03-15 |
PT1450785E (pt) | 2007-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1106528T1 (el) | Μεθοδος θεραπειας δερματωσεων με τη χρηση ενωσης αβερμεκτινης | |
CY1121135T1 (el) | Ενωσεις υποκατεστημενης τετρακυκλιnhς για την θεραπευτικη αγωγη φλεγμονωδων διαταραχων του δερματος | |
DK3248600T3 (da) | Kombinationer og måder til administration af terapeutiske stoffer og kombinationsterapi | |
BR0312671A (pt) | Dispositivo de microagulhas, método para utilizar um dispositivo de microagulhas, e, método para aplicar um dispositivo de microagulhas | |
LTC1620113I2 (lt) | Ivermektino topinė kompozicija, skirta dermatologinių susirgimų gydymui | |
EA200000282A1 (ru) | Способ введения таксана пациенту, нуждающемуся в лечении таксаном, способ лечения человека таксаном (варианты) | |
CY1110889T1 (el) | C-αρυλο γλυκοζιτικοι sglt2 αναστολεις και μεθοδος για την παραγωγη τους | |
DE60132077D1 (de) | Vitaminzusammenstellung mit verzögerter freigabe | |
WO2007014106A3 (en) | System and method of delivering radiation therapy to a moving region of interest | |
CY1108250T1 (el) | Διαδερμικο θεραπευτικο συστημα για τη χορηγηση μη στεροειδικων αντιφλογιστικων που φερουν καρβοξυλομαδες, καθως και μεθοδος για την παραγωγη του | |
TW200730211A (en) | System and method of delivering radiation therapy to a moving region of interest | |
AR049518A1 (es) | Composicion farmaceutica que comprende un agente siliconado y dos principios activos solubilizados | |
NO20071426L (no) | Kreft kombinasjonsbehandling omfattende AZD2171 og Imatinib | |
DK1423384T3 (da) | Pyridinderivater som Raf kinaseinhibitorer | |
CL2007003331A1 (es) | Metodo para tratar cancer mediante la administracion de un agente radiosensibilizante derivado de benzo[a]trinden-4,6-diona; composicion farmaceutica que comprende dicho agente. | |
WO2015017328A3 (en) | Organophosphates for treating afflictions of the skin | |
NO20072668L (no) | Ny kombinasjon | |
PE20040990A1 (es) | Combinaciones de inhibidores de quinasa de erb b y farmacos antineoplasicos | |
BR0215362A (pt) | método para melhorar a aparência estética da pele | |
BR112012014107B8 (pt) | sistema terapêutico transdérmico (tts) e processo de produção de tts | |
DE502005008109D1 (de) | Bestrahlungseinrichtung | |
DE60220179D1 (de) | Substituierte benzopyrane als selektive agonisten am östrogenrezeptor-beta | |
DK1626974T3 (da) | Substituerede benzopyraner som selektive östrogenreceptor-beta-agonister | |
DK1276482T3 (da) | Kombinationskemoterapi | |
AR052346A1 (es) | Composicion que comprende una epotilona y metodos para producir dicha composicion |